Endothelial CD146 is required for in vitro tumor-induced angiogenesis: The role of a disulfide bond in signaling and dimerization

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 11, 2009, Pages 2163-2172

  Zheng, Chaogu ^a,b,c   Qiu, Yijun ^a,b   Zeng, Qiqun ^a,b,c   Zhang, Ying ^a,b,c   Lu, Di ^a,b   Yang, Dongling ^a,b   Feng, Jing ^a,b   Yan, Xiyun ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

CD146; Dimerization; Disulfide bond; NF B; Tumor angiogenesis

Indexed keywords

CD146 ANTIGEN; GELATINASE B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AA98; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CELL SECRETION; CHO CELL; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; ENDOTHELIUM CELL; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CARCINOMA; NONHUMAN; PROTEIN FUNCTION; PROTEIN INDUCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR VASCULARIZATION; UMBILICAL VEIN;

EID: 70349299880     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.03.014     Document Type: Article

References (30)

1. Anfosso F., Bardin N., Frances V., Vivier E., Camoin-Jau L., Sampol J., et al. Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125(FAK). J Biol Chem 273 (1998) 26852-26856
2. Anfosso F., Bardin N., Vivier E., Sabatier F., Sampol J., and Dignat-George F. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem 276 (2001) 1564-1569
3. Bardin N., George F., Mutin M., Brisson C., Horschowski N., Frances V., et al. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 48 (1996) 531-539
4. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
5. Blackwell T.S., and Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17 (1997) 3-9
6. Bowie A., Moynagh P.N., and O'Neill L.A. Mechanism of NF kappa B activation by interleukin-1 and tumour necrosis factor in endothelial cells. Biochem Soc Trans 24 (1996) 2S
7. Bu P., Gao L., Zhuang J., Feng J., Yang D., and Yan X. Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation. Mol Cancer Ther 5 (2006) 2872-2878
8. Bu P., Zhuang J., Feng J., Yang D., Shen X., and Yan X. Visualization of CD146 dimerization and its regulation in living cells. Biochim Biophys Acta 1773 (2007) 513-520
9. Guezguez B., Vigneron P., Lamerant N., Kieda C., Jaffredo T., and Dunon D. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J Immunol 179 (2007) 6673-6685
10. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
11. Johnson J.P., Rothbacher U., and Sers C. The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family. Melanoma Res 3 (1993) 337-340
12. Kang Y., Wang F., Feng J., Yang D., Yang X., and Yan X. Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res 16 (2006) 313-318
13. Leibovich S.J., Polverini P.J., Shepard H.M., Wiseman D.M., Shively V., and Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329 (1987) 630-632
14. Li S., Schmitz K.R., Jeffrey P.D., Wiltzius J.J., Kussie P., and Ferguson K.M. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7 (2005) 301-311
15. Miyake T., Aoki M., Shiraya S., Tanemoto K., Ogihara T., Kaneda Y., et al. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J Mol Cell Cardiol 41 (2006) 431-440
16. Monaco C., and Paleolog E. Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 61 (2004) 671-682
17. Murley J.S., Kataoka Y., Hallahan D.E., Roberts J.C., and Grdina D.J. Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Radic Biol Med 30 (2001) 1426-1439
18. Nagata D., Mogi M., and Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 278 (2003) 31000-31006
19. Naidu B.V., Farivar A.S., Woolley S.M., Byrne K., and Mulligan M.S. Chemokine response of pulmonary artery endothelial cells to hypoxia and reoxygenation. J Surg Res 114 (2003) 163-171
20. Roebuck K.A. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (review). Int J Mol Med 4 (1999) 223-230
21. Sers C., Riethmuller G., and Johnson J.P. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread. Cancer Res 54 (1994) 5689-5694
22. Shono T., Ono M., Izumi H., Jimi S.I., Matsushima K., Okamoto T., et al. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 16 (1996) 4231-4239
23. St-Pierre Y., Couillard J., and Van Themsche C. Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases. Expert Opin Ther Targets 8 (2004) 473-489
24. Ulfhammer E., Larsson P., Karlsson L., Hrafnkelsdottir T., Bokarewa M., Tarkowski A., et al. TNF-alpha mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-kappaB- and p38 MAPK-dependent. J Thromb Haemost 4 (2006) 1781-1789
25. Voronov E., Shouval D.S., Krelin Y., Cagnano E., Benharroch D., Iwakura Y., et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100 (2003) 2645-2650
26. Wang J.N., Feng J.N., Yu M., Xu M., Shi M., Zhou T., et al. Structural analysis of the epitopes on erbB2 interacted with inhibitory or non-inhibitory monoclonal antibodies. Mol Immunol 40 (2004) 963-969
27. Xie S., Luca M., Huang S., Gutman M., Reich R., Johnson J.P., et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 57 (1997) 2295-2303
28. Yan X., Lin Y., Yang D., Shen Y., Yuan M., Zhang Z., et al. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102 (2003) 184-191
29. Zhang Y., Zheng C., Zhang J., Yang D., Feng J., Lu D., et al. Generation and characterization of a panel of monoclonal antibodies against distinct epitopes of human CD146. Hybridoma (Larchmt) 27 (2008) 345-352
30. Zhen J., Lu H., Wang X.Q., Vaziri N.D., and Zhou X.J. Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 21 (2008) 28-34